The candidate vaccine will have two doses with a 22-day interval between them. Clinical development is sponsored by China-based Sichuan Clover Biopharmaceuticals.
The amount of people infected since the beginning of the pandemic now stands at 13,746,681. In 24 hours, 73,174 new positive diagnoses were confirmed.
The threshold of 53.9 million doses distributed should be reached Friday (16), after 6.3 million doses are sent to states and the Federal District.